PFREUNDSCHUH PETER P.

FollowCreate a free account to set a filing alert.

EVP, CFO and Treasurer at Y-mAbs Therapeutics, Inc. · on record since Jul 12, 2024
Chief Financial Officer at IMMUNOMEDICS INC · on record since Sep 4, 2013
CFO at Sucampo Pharmaceuticals, Inc. · on record since Mar 22, 2017
Chief Financial Officer at UroGen Pharma Ltd. · on record since Aug 22, 2019
Chief Financial Officer at Korro Bio, Inc. · on record since Dec 3, 2020
Chief Financial Officer at Voyager Therapeutics, Inc. · on record since Sep 21, 2022

Insider trading activity of PFREUNDSCHUH PETER P.

Transactions on record: 74; since Sep 4, 2013

Purchases: 0

Sales: 18; $317.2K

Companies traded: 6; last filing Sep 18, 2025

Figures computed from official regulatory filings — .

Companies where PFREUNDSCHUH PETER P. has traded

Y-mAbs Therapeutics, Inc.9 tx · Sep 18, 2025
Voyager Therapeutics, Inc.8 tx · $122.9K · Feb 22, 2024
Korro Bio, Inc.11 tx · $27.6K · Feb 23, 2022
UroGen Pharma Ltd.35 tx · $166.7K · Oct 16, 2020
Sucampo Pharmaceuticals, Inc.5 tx · $1.1M · Feb 13, 2018
IMMUNOMEDICS INC6 tx · Aug 24, 2015

Track record of PFREUNDSCHUH PETER P.

Insufficient history for a statistical track record (fewer than 5 purchases).

Transaction history of PFREUNDSCHUH PETER P.

Co-insiders of PFREUNDSCHUH PETER P.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Y-mAbs Therapeutics, Inc.Listing unverified	Sep 18, 2025	OtherD (derivative)	-15,900	—	n/a (No price was disclosed in the filing)		SEC
Y-mAbs Therapeutics, Inc.Listing unverified	Sep 18, 2025	Other	-77,800	—	n/a (No price was disclosed in the filing)		SEC
Y-mAbs Therapeutics, Inc.Listing unverified	Sep 18, 2025	OtherD (derivative)	-170,000	—	n/a (No price was disclosed in the filing)		SEC
Y-mAbs Therapeutics, Inc.Listing unverified	Sep 18, 2025	OtherD (derivative)	-15,900	—	n/a (No price was disclosed in the filing)		SEC
Y-mAbs Therapeutics, Inc.Listing unverified	Sep 18, 2025	OtherD (derivative)	-63,500	—	n/a (No price was disclosed in the filing)		SEC
Y-mAbs Therapeutics, Inc.Listing unverified	Jan 22, 2025	AwardD (derivative)	63,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Y-mAbs Therapeutics, Inc.Listing unverified	Jan 22, 2025	Award	31,800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Y-mAbs Therapeutics, Inc.Listing unverified	Jul 12, 2024	Award	46,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Y-mAbs Therapeutics, Inc.Listing unverified	Jul 12, 2024	AwardD (derivative)	170,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Voyager Therapeutics, Inc.Listing on record	Feb 22, 2024	Sell	-3,764	7.46 USD	$28.1K		SEC
Voyager Therapeutics, Inc.Listing on record	Feb 16, 2024	Award	30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Voyager Therapeutics, Inc.Listing on record	Feb 16, 2024	AwardD (derivative)	60,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Voyager Therapeutics, Inc.Listing on record	Oct 5, 2023	Sell	-13,567	6.99 USD	$94.8K	Unusual size	SEC
Voyager Therapeutics, Inc.Listing on record	Feb 22, 2023	AwardD (derivative)	76,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Voyager Therapeutics, Inc.Listing on record	Feb 22, 2023	Award	38,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Voyager Therapeutics, Inc.Listing on record	Oct 4, 2022	Award	125,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Voyager Therapeutics, Inc.Listing on record	Sep 21, 2022	AwardD (derivative)	200,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Korro Bio, Inc.Listing on record	Feb 23, 2022	Sell	-1,404	3.88 USD	$5.4K		SEC
Korro Bio, Inc.Listing on record	Feb 23, 2022	Sell	-1,542	3.53 USD	$5.4K		SEC
Korro Bio, Inc.Listing on record	Feb 18, 2022	AwardD (derivative)	150,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Korro Bio, Inc.Listing on record	Feb 18, 2022	Sell	-1,296	4.20 USD	$5.4K		SEC
Korro Bio, Inc.Listing on record	Feb 18, 2022	Sell	-1,229	4.43 USD	$5.4K		SEC
Korro Bio, Inc.Listing on record	Feb 16, 2022	ExerciseD (derivative)	-15,000	—	n/a (No price was disclosed in the filing)		SEC
Korro Bio, Inc.Listing on record	Feb 16, 2022	Sell	-1,347	4.33 USD	$5.8K		SEC
Korro Bio, Inc.Listing on record	Feb 16, 2022	Exercise	15,000	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Y-mAbs Therapeutics, Inc.Listing unverified	Sep 18, 2025	OtherD (derivative)	-15,900	—	n/a (No price was disclosed in the filing)		SEC
Y-mAbs Therapeutics, Inc.Listing unverified	Sep 18, 2025	Other	-77,800	—	n/a (No price was disclosed in the filing)		SEC
Y-mAbs Therapeutics, Inc.Listing unverified	Sep 18, 2025	OtherD (derivative)	-170,000	—	n/a (No price was disclosed in the filing)		SEC
Y-mAbs Therapeutics, Inc.Listing unverified	Sep 18, 2025	OtherD (derivative)	-15,900	—	n/a (No price was disclosed in the filing)		SEC
Y-mAbs Therapeutics, Inc.Listing unverified	Sep 18, 2025	OtherD (derivative)	-63,500	—	n/a (No price was disclosed in the filing)		SEC
Y-mAbs Therapeutics, Inc.Listing unverified	Jan 22, 2025	AwardD (derivative)	63,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Y-mAbs Therapeutics, Inc.Listing unverified	Jan 22, 2025	Award	31,800	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Y-mAbs Therapeutics, Inc.Listing unverified	Jul 12, 2024	Award	46,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Y-mAbs Therapeutics, Inc.Listing unverified	Jul 12, 2024	AwardD (derivative)	170,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Voyager Therapeutics, Inc.Listing on record	Feb 22, 2024	Sell	-3,764	7.46 USD	$28.1K		SEC
Voyager Therapeutics, Inc.Listing on record	Feb 16, 2024	Award	30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Voyager Therapeutics, Inc.Listing on record	Feb 16, 2024	AwardD (derivative)	60,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Voyager Therapeutics, Inc.Listing on record	Oct 5, 2023	Sell	-13,567	6.99 USD	$94.8K	Unusual size	SEC
Voyager Therapeutics, Inc.Listing on record	Feb 22, 2023	AwardD (derivative)	76,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Voyager Therapeutics, Inc.Listing on record	Feb 22, 2023	Award	38,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Voyager Therapeutics, Inc.Listing on record	Oct 4, 2022	Award	125,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Voyager Therapeutics, Inc.Listing on record	Sep 21, 2022	AwardD (derivative)	200,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Korro Bio, Inc.Listing on record	Feb 23, 2022	Sell	-1,404	3.88 USD	$5.4K		SEC
Korro Bio, Inc.Listing on record	Feb 23, 2022	Sell	-1,542	3.53 USD	$5.4K		SEC
Korro Bio, Inc.Listing on record	Feb 18, 2022	AwardD (derivative)	150,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Korro Bio, Inc.Listing on record	Feb 18, 2022	Sell	-1,296	4.20 USD	$5.4K		SEC
Korro Bio, Inc.Listing on record	Feb 18, 2022	Sell	-1,229	4.43 USD	$5.4K		SEC
Korro Bio, Inc.Listing on record	Feb 16, 2022	ExerciseD (derivative)	-15,000	—	n/a (No price was disclosed in the filing)		SEC
Korro Bio, Inc.Listing on record	Feb 16, 2022	Sell	-1,347	4.33 USD	$5.8K		SEC
Korro Bio, Inc.Listing on record	Feb 16, 2022	Exercise	15,000	—	n/a (No price was disclosed in the filing)		SEC